- Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
- Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
- Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
- Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
- Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
- Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
More ▼
Key statistics
On Thursday, Galera Therapeutics Inc (GRTX:NMQ) closed at 0.1936, 126.96% above the 52 week low of 0.0853 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1852 |
---|---|
High | 0.204 |
Low | 0.1852 |
Bid | 0.1902 |
Offer | 0.204 |
Previous close | 0.1898 |
Average volume | 790.33k |
---|---|
Shares outstanding | 54.39m |
Free float | 40.69m |
P/E (TTM) | -- |
Market cap | 10.32m USD |
EPS (TTM) | -1.42 USD |
Data delayed at least 15 minutes, as of May 02 2024 21:00 BST.
More ▼